Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
18. März 2024 07:05 ET
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.